| Literature DB >> 27288827 |
Abstract
The prevalence of obesity calls for novel therapeutic targets. The melanocortin-3 receptor (MC3R) has been increasingly recognized as an important regulator of energy homeostasis and MC3R has been intensively analyzed in molecular genetic studies for obesity-related traits. Twenty-seven MC3R mutations and two common polymorphic variants have been identified so far in different cohorts. The mutant MC3Rs demonstrate multiple defects in functional analysis and can be cataloged into different classes according to receptor life cycle based classification system. Although the pathogenic role of MC3R in human obesity remains controversial, recent findings in the noncanonical signaling pathway of MC3R mutants have provided new insights. Potential therapeutic strategies for obesity related to MC3R mutations are highlighted.Entities:
Keywords: adiposity; melanocortin-3 receptor; obesity; pharmacology; signaling
Mesh:
Substances:
Year: 2016 PMID: 27288827 DOI: 10.1016/bs.pmbts.2016.01.002
Source DB: PubMed Journal: Prog Mol Biol Transl Sci ISSN: 1877-1173 Impact factor: 3.622